16 results on '"Bailey, Kristian"'
Search Results
2. Impact of age and sex on heart rate variability and cardiometabolic function in healthy adults
- Author
-
Alyahya, Alaa I., Charman, Sarah J., Okwose, Nduka C., Fuller, Amy S., Eggett, Christopher, Luke, Peter, Bailey, Kristian, MacGowan, Guy A., and Jakovljevic, Djordje G.
- Published
- 2024
- Full Text
- View/download PDF
3. Haemodynamic determinants of quality of life in chronic heart failure
- Author
-
Fatrin, Serlie, Okwose, Nduka C., Bailey, Kristian, Velicki, Lazar, Popovic, Dejana, Ristic, Arsen, Seferovic, Petar M., MacGowan, Guy A., and Jakovljevic, Djordje G.
- Published
- 2022
- Full Text
- View/download PDF
4. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study
- Author
-
Gniot, Jacek, Mozheiko, Maria, Lelonek, Malgorzata, Dominguez, Antonio Reyes, Horacek, Thomas, Garcia del Rio, Enrique, Kobalava, Zhanna, Mueller, Christian Eugen, Cavusoglu, Yuksel, Straburzynska-Migaj, Ewa, Slanina, Miroslav, vom Dahl, Juergen, Senni, Michele, Ryding, Alisdair, Moriarty, Andrew, Robles, Manuel Beltran, Villota, Julio Nunez, Quintana, Antonio Garcia, Nitschke, Thorsten, Garcia Pinilla, Jose Manuel, Bonet, Luis Almenar, Chaaban, Said, Filali zaatari, Samia, Spinar, Jindrich, Musial, Wlodzimierz, Abdelbaki, Khaled, Belohlavek, Jan, Fehske, Wolfgang, Bott, Michael Carlos, Hoegalmen, Geir, Leiro, Marisa Crespo, Ozcan, Ismail Turkay, Mullens, Wilfried, Kryza, Radim, Al-Ani, Riadh, Loboz-Grudzien, Krystyna, Ermoshkina, Lyudmila, Hojerova, Silvia, Fernandez, Alberto Alfredo, Spinarova, Lenka, Lapp, Harald, Bulut, Efraim, Almeida, Filipa, Vishnevsky, Alexander, Belicova, Margita, Pascual, Domingo, Witte, Klaus, Wong, Kenneth, Droogne, Walter, Delforge, Marc, Peterka, Martin, Olbrich, Hans-Georg, Carugo, Stefano, Nessler, Jadwiga, McGill, Thao Huynh, Huegl, Burkhard, Akin, Ibrahim, Moreira, Ilidio, Baglikov, Andrey, Thambyrajah, Jeetendra, Hayes, Chris, Barrionuevo, Marcelo Raul, Yigit, Zerrin, Kaya, Hakki, Klimsa, Zdenek, Radvan, Martin, Kadel, Christoph, Landmesser, Ulf, Di Tano, Giuseppe, Lisik, Malgorzata Buksinska, Fonseca, Candida, Oliveira, Luis, Marques, Irene, Santos, Luis Miguel, Lenner, Egon, Letavay, Peter, Bueno, Manuel Gomez, Mota, Paula, Wong, Aaron, Bailey, Kristian, Foley, Paul, Hasbani, Eduardo, Virani, Sean, Massih, Tony Abdel, Al-Saif, Shukri, Taborsky, Milos, Kaislerova, Marta, Motovska, Zuzana, Cohen, Aron Ariel, Logeart, Damien, Endemann, Dierk, Ferreira, Daniel, Brito, Dulce, Kycina, Peter, Bollano, Entela, Basilio, Enrique Galve, Rubio, Lorenzo Facila, Aguado, Marcos Garcia, Schiavi, Lilia Beatriz, Zivano, Daniel Francisco, Lonn, Eva, El Sayed, Ali, Pouleur, Anne-Catherine, Heyse, Alex, Schee, Alexandr, Polasek, Rostislav, Houra, Marek, Tribouilloy, Christophe, Seronde, Marie France, Galinier, Michel, Noutsias, Michel, Schwimmbeck, Peter, Voigt, Ingo, Westermann, Dirk, Pulignano, Giovanni, Vegsundvaag, Johnny, Da Silva Antunes, Jose Alexandre, Monteiro, Pedro, Stevlik, Jan, Goncalvesova, Eva, Hulkoova, Beata, Castro Fernandez, Antonio Juan, Davies, Ceri, Squire, Iain, Meyer, Philippe, Sheppard, Richard, Sahin, Tayfun, Sochor, Karel, De Geeter, Guillaume, Wachter, Rolf, Schmeisser, Alexander, Weil, Joachim, Soares, Ana Oliveira, Vasilevna, Olga Bulashova, Oshurkov, Andrey, Sunderland, Shahid Junejo, Glover, Jason, Exequiel, Tomas, Decoulx, Eric, Meyer, Sven, Muenzel, Thomas, Frioes, Fernando, Arbolishvili, Georgy, Tokarcikova, Anna, Karlstrom, Patric, Trullas Vila, Joan Carles, Perez, Gonzalo Pena, Sankaranarayanan, Rajiv, Nageh, Thuraia, Alasia, Diego Cristian, Refaat, Marwan, Demirkan, Burcu, Al-Buraiki, Jehad, Karabsheh, Shadi, Pascual-Figal, Domingo, Bao, Weibin, Noè, Adele, Schwende, Heike, Butylin, Dmytro, and Prescott, Margaret F.
- Published
- 2020
- Full Text
- View/download PDF
5. ON SOLIDARITY DELEGATIONS
- Author
-
ABUZNAID, AHMAD, AGNEW, PHILLIP, ALHASSEN, MAYTHA, BAILEY, KRISTIAN DAVIS, and TANNOUS, NADYA
- Published
- 2019
6. Physical Activity, Inactivity and Sleep in Individuals with Hypertrophic Cardiomyopathy.
- Author
-
Charman, Sarah J, Blain, Alasdair P, Okwose, Nduka C, Fuller, Amy S, Alyahya, Alaa I, Hallsworth, Kate, Eggett, Christopher, Luke, Peter, Bailey, Kristian, MacGowan, Guy A, and Jakovljevic, Djordje G
- Subjects
SEDENTARY lifestyles ,STATISTICS ,HUMAN research subjects ,CARDIAC hypertrophy ,AGE distribution ,TIME ,OXYGEN consumption ,ACCELEROMETERS ,PHYSICAL activity ,SLEEP duration ,SEX distribution ,INFORMED consent (Medical law) ,QUALITY of life ,ANALYSIS of covariance ,DESCRIPTIVE statistics ,RESEARCH funding ,BODY mass index ,DATA analysis software ,DATA analysis - Abstract
Physical activity presents an important cornerstone in the management and care of individuals with hypertrophic cardiomyopathy (HCM). Twenty-one individuals with HCM (age: 52±15 years old, body mass index (BMI): 30±7 kg/m
2 ) completed 7-day monitoring using wrist-worn triaxial accelerometers (GENEActiv, ActivInsights Ltd, UK) and were compared to age and sex-matched healthy controls (age: 51±14 years old, BMI: 25±4 kg/m2 ). For individuals with HCM, clinical parameters (left atrial diameter and volume, peak oxygen consumption, NTproBNP and Minnesota Living with Heart Failure (MLHF)) were correlated with accelerometry. After adjusting for BMI, individuals with HCM spent less time in moderate-vigorous physical activity (MVPA) (86 (55–138) vs. 140 (121–149) minutes/day, p <0.05) compared to healthy controls. Individuals with HCM engaged in fewer MVPA-5 min (6 (2–15) vs. 27 (23–37) minutes/day, p <0.01) and MVPA-10 min bouts (9 (0–19) vs. 35 (17–54) minutes/day, p <0.01) versus healthy controls. For HCM only, peak oxygen consumption was correlated with MVPA (r =0.60, p <0.01) and MVPA-5 min bouts (r =0.47, p <0.05). MLHF score was correlated with slee p duration (r =0.45, p <0.05). Individuals with HCM should be encouraged to engage in moderate-intensity physical activity bouts and reduce prolonged periods of inactivity in order to potentially improve exercise tolerance and reduce disease burden. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
7. Acceptability, Feasibility and Preliminary Evaluation of a Novel, Personalised, Home-Based Physical Activity Intervention for Chronic Heart Failure (Active-at-Home-HF): a Pilot Study
- Author
-
Okwose, Nduka C., Avery, Leah, O’Brien, Nicola, Cassidy, Sophie, Charman, Sarah J., Bailey, Kristian, Velicki, Lazar, Olivotto, Iacopo, Brennan, Paul, MacGowan, Guy A., and Jakovljevic, Djordje G.
- Published
- 2019
- Full Text
- View/download PDF
8. Heart rate variability and haemodynamic function in individuals with hypertrophic cardiomyopathy.
- Author
-
Alyahya, Alaa I., Charman, Sarah J., Okwose, Nduka C., Fuller, Amy S., Eggett, Christopher, Luke, Peter, Bailey, Kristian, MacGowan, Guy A., and Jakovljevic, Djordje G.
- Subjects
HEART beat ,HYPERTROPHIC cardiomyopathy ,HEMODYNAMICS ,BODY mass index - Abstract
Objectives: Heart rate variability (HRV) is a measure of cardiac autonomic function. This study: (1) evaluated the differences in HRV and haemodynamic function between individuals with hypertrophic cardiomyopathy (HCM) and healthy controls, and (2) determined the relationship between HRV and haemodynamic variables in individuals with HCM. Methods: Twenty‐eight individuals with HCM (n = 7, females; age 54 ± 15 years; body mass index: 29 ± 5 kg/m2) and 28 matched healthy individuals (n = 7 females; age 54 ± 16 years; body mass index: 29 ± 5 kg/m2) completed 5‐min HRV and haemodynamic measurements under resting (supine) conditions using bioimpedance technology. Frequency domain HRV measures (absolute and normalized low‐frequency power (LF), high‐frequency power (HF) and LF/HF ratio) and RR interval were recorded. Results: Individuals with HCM demonstrated higher vagal activity (i.e., absolute unit of HF power (7.40 ± 2.50 vs. 6.03 ± 1.35 ms2, p = 0.01) but lower RR interval (914 ± 178 vs. 1014 ± 168 ms, p = 0.03) compared to controls. Stroke volume (SV) index and cardiac index were lower in HCM compared with healthy individuals (SV, 33 ± 9 vs. 43 ± 7 ml/beat/m², p < 0.01; cardiac index,2.33 ± 0.42 vs. 3.57 ± 0.82 L/min/m2, p < 0.01), but total peripheral resistance (TPR) was higher in HCM (3468 ± 1027 vs. 2953 ± 1050 dyn·s·m2cm−5, p = 0.03). HF power was significantly related to SV (r = −0.46, p < 0.01) and TPR (r = 0.28, p < 0.05) in HCM. Conclusions: Short‐term frequency domain indices of HRV provide a feasible approach to assess autonomic function in individuals with HCM. Vagal activity, represented by HF power, is increased, and associated with peripheral resistance in individuals with HCM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Feasibility of the cardiac output response to stress test in suspected heart failure patients.
- Author
-
Charman, Sarah J, Okwose, Nduka C, Taylor, Clare J, Bailey, Kristian, Fuat, Ahmet, Ristic, Arsen, Mant, Jonathan, Deaton, Christi, Seferovic, Petar M, Coats, Andrew J S, Hobbs, F D Richard, MacGowan, Guy A, and Jakovljevic, Djordje G
- Subjects
HEART failure ,STRESS echocardiography ,HEART failure patients ,CARDIAC output ,GENERAL practitioners - Abstract
Background: Diagnostic tools available to support general practitioners diagnose heart failure (HF) are limited.Objectives: (i) Determine the feasibility of the novel cardiac output response to stress (CORS) test in suspected HF patients, and (ii) Identify differences in the CORS results between (a) confirmed HF patients from non-HF patients, and (b) HF reduced (HFrEF) vs HF preserved (HFpEF) ejection fraction.Methods: Single centre, prospective, observational, feasibility study. Consecutive patients with suspected HF (N = 105; mean age: 72 ± 10 years) were recruited from specialized HF diagnostic clinics in secondary care. The consultant cardiologist confirmed or refuted a HF diagnosis. The patient completed the CORS but the researcher administering the test was blinded from the diagnosis. The CORS assessed cardiac function (stroke volume index, SVI) noninvasively using the bioreactance technology at rest-supine, challenge-standing, and stress-step exercise phases.Results: A total of 38 patients were newly diagnosed with HF (HFrEF, n = 21) with 79% being able to complete all phases of the CORS (91% of non-HF patients). A 17% lower SVI was found in HF compared with non-HF patients at rest-supine (43 ± 15 vs 51 ± 16 mL/beat/m2, P = 0.02) and stress-step exercise phase (49 ± 16 vs 58 ± 17 mL/beat/m2, P = 0.02). HFrEF patients demonstrated a lower SVI at rest (39 ± 15 vs 48 ± 13 mL/beat/m2, P = 0.02) and challenge-standing phase (34 ± 9 vs 42 ± 12 mL/beat/m2, P = 0.03) than HFpEF patients.Conclusion: The CORS is feasible and patients with HF responded differently to non-HF, and HFrEF from HFpEF. These findings provide further evidence for the potential use of the CORS to improve HF diagnostic and referral accuracy in primary care. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
10. Roundtable ON SOLIDARITY DELEGATIONS.
- Author
-
ABUZNAID, AHMAD, AGNEW, PHILLIP, ALHASSEN, MAYTHA, BAILEY, KRISTIAN DAVIS, and TANNOUS, NADYA
- Subjects
SOLIDARITY ,WORLD War II - Abstract
Delegations of Black revolutionary leaders to the Middle East were a prominent feature of Black-Palestinian transnational solidarity at the height of the worldwide revolt against imperial domination in the decades following World War II. Though they never ceased, delegations have become a critical feature of solidarity practices once more. Unlike their historical predecessors, today's delegations are no longer organized in collaboration with the official organizations of the Palestinian national movement but between individuals and/or social justice organizations. In addition, the delegations are no longer unidirectional, as they now encompass visits by activists from Palestine and other "Palestinian geographies" in the Middle East to the United States. Finally, recent delegations have included one by indigenous youth to Palestine and several from the African continent to the Middle East. This roundtable, featuring leading organizers of recent delegations, aims to reveal the ruptures and continuities of a historical legacy. We intend for this roundtable to serve as an archive and a site of knowledge production. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. Association between heart rate variability and haemodynamic response to exercise in chronic heart failure.
- Author
-
Koshy, Aaron, Okwose, Nduka C., Toms, Anet, MacGowan, Guy A., Jakovljevic, Djordje G., Nunan, David, Brodie, David A., Doherty, Patrick, Seferovic, Petar, Ristic, Arsen, Popovic, Dejana, Velicki, Lazar, Filipovic, Nenad, Skinner, Jane, and Bailey, Kristian
- Subjects
HEART beat ,HEART failure ,CARDIAC output ,EXERCISE tests ,VENTRICULAR ejection fraction - Abstract
Objectives: Heart rate variability (HRV) and haemodynamic response to exercise (i.e. peak cardiac power output) are strong predictors of mortality in heart failure. The present study assessed the relationship between measures of HRV and peak cardiac power output.Design: In a prospective observational study of 33 patients (age 54 ± 16 years) with chronic heart failure with reduced left ventricular ejection fraction (29 ± 11%), measures of the HRV (i.e. R-R interval and standard deviation of normal R-R intervals, SDNN) were recorded in a supine position. All patients underwent maximal graded cardiopulmonary exercise testing with non-invasive (inert gas rebreathing) cardiac output assessment. Cardiac power output, expressed in watts, was calculated as the product of cardiac output and mean arterial blood pressure.Results: The mean RR and SDNN were 837 ± 166 and 96 ± 29 ms, peak exercise cardiac power output 2.28 ± 0.85 watts, cardiac output 10.34 ± 3.14 L/min, mean arterial blood pressure 98 ± 14 mmHg, stroke volume 91.43 ± 40.77 mL/beat, and oxygen consumption 19.0 ± 5.6 mL/kg/min. There was a significant but only moderate relationship between the RR interval and peak exercise cardiac power output (r = 0.43, p = .013), cardiac output (r = 0.35, p = .047), and mean arterial blood pressure (r = 0.45, p = .009). The SDNN correlated with peak cardiac power output (r = 0.42, p = .016), mean arterial blood arterial (r = 0.41, p = .019), and stroke volume (r = 0.35, p = .043).Conclusions: Moderate strength of the relationship between measures of HRV and cardiac response to exercise suggests that cardiac autonomic function is not good indicator of overall function and pumping capability of the heart in chronic heart failure. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
12. NT‐proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure.
- Author
-
Parovic, Milos, Okwose, Nduka C., Bailey, Kristian, Velicki, Lazar, Fras, Zlatko, Seferovic, Petar M., MacGowan, Guy A., and Jakovljevic, Djordje G.
- Subjects
HEART failure treatment ,BRAIN natriuretic factor ,HEMODYNAMICS - Abstract
Aims: N‐terminal prohormone of brain natriuretic peptide (NT‐proBNP) plays an important role in diagnosis and management of heart failure. The aim of the present study was to assess haemodynamic response to exercise and to evaluate the relationship between NT‐proBNP, cardiac function, and exercise tolerance in chronic heart failure. Methods and results: A single‐centre, cross‐sectional pilot study recruited 17 patients with chronic heart failure with reduced left ventricular ejection fraction (age 67 ± 7 years) and 20 healthy volunteers (age 65 ± 12 years). The NT‐proBNP was measured in the heart failure group. All participants completed maximal graded cardiopulmonary exercise stress testing coupled with gas exchange (using metabolic analyser for determination of exercise tolerance, i.e. peak O2 consumption) and continuous haemodynamic measurements (i.e. cardiac output and cardiac power output) using non‐invasive bioreactance technology. Heart failure patients demonstrated significantly lower peak exercise cardiac function and exercise tolerance than healthy controls, i.e. cardiac power output (5.0 ± 2.0 vs. 3.2 ± 1.2 W, P < 0.01), cardiac output (18.2 ± 6.3 vs. 13.5 ± 4.0 L/min, P < 0.01), heart rate (148 ± 23.7 vs. 111 ± 20.9 beats/min, P < 0.01), and oxygen consumption (24.3 ± 9.5 vs. 16.8 ± 3.8 mL/kg/min, P < 0.01). There was no significant relationship between NT‐proBNP and cardiac function at rest, i.e. cardiac power output (r = −0.28, P = 0.28), cardiac output (r = −0.18, P = 0.50), and oxygen consumption (r = −0.18, P = 0.50), or peak exercise, i.e. cardiac power output (r = 0.18, P = 0.49), cardiac output (r = 0.13, P = 0.63), and oxygen consumption (r = −0.05, P = 0.84). Conclusions: Lack of a significant and strong relationship between the NT‐proBNP and measures of cardiac function and exercise tolerance may suggest that natriuretic peptides should be considered with caution in interpretation of the severity of cardiac dysfunction and functional capacity in chronic heart failure. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
13. A novel cardiac output response to stress test developed to improve diagnosis and monitoring of heart failure in primary care.
- Author
-
Charman, Sarah J., Okwose, Nduka C., Stefanetti, Renae J., Bailey, Kristian, Skinner, Jane, Ristic, Arsen, Seferovic, Petar M., Scott, Mike, Turley, Stephen, Fuat, Ahmet, Mant, Jonathan, Hobbs, Richard F. D., MacGowan, Guy A., and Jakovljevic, Djordje G.
- Abstract
Abstract: Aims: Primary care physicians lack access to an objective cardiac function test. This study for the first time describes a novel cardiac output response to stress (CORS) test developed to improve diagnosis and monitoring of heart failure in primary care and investigates its reproducibility. Methods and results: Prospective observational study recruited 32 consecutive primary care patients (age, 63 ± 9 years; female, n = 18). Cardiac output was measured continuously using the bioreactance method in supine and standing positions and during two 3 min stages of a step‐exercise protocol (10 and 15 steps per minute) using a 15 cm height bench. The CORS test was performed on two occasions, i.e. Test 1 and Test 2. There was no significant difference between repeated measures of cardiac output and stroke volume at supine standing and Stage 1 and Stage 2 step exercises (all P > 0.3). There was a significant positive relationship between Test 1 and Test 2 cardiac outputs (r = 0.92, P = 0.01 with coefficient of variation of 7.1%). The mean difference in cardiac output (with upper and lower limits of agreement) between Test 1 and Test 2 was 0.1 (−1.9 to 2.1) L/min, combining supine, standing, and step‐exercise data. Conclusions: The CORS, as a novel test for objective evaluation of cardiac function, demonstrates acceptable reproducibility and can potentially be implemented in primary care. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
14. Change in Serum Lipids after Acute Coronary Syndromes: Secondary Analysis of SPACE ROCKET Study Data and a Comparative Literature Review.
- Author
-
Barth, Julian H., Jackson, Beryl M., Farrin, Amanda J., Efthymiou, Maria, Worthy, Gillian, Copeland, Joanne, Bailey, Kristian M., Romaine, Simon P.R., Balmforth, Anthony J., McCormack, Terry, Whitehead, Andrew, Flather, Marcus D., Nixon, Jane, and Hall, Alistair S.
- Published
- 2010
15. Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction.
- Author
-
Bailey, Kristian M., Romaine, Simon P. R., Jackson, Beryl M., Farrin, Amanda J., Efthymiou, Maria, Barth, Julian H., Copeland, Joanne, McCormack, Terry, Whitehead, Andrew, Flather, Marcus D., Samani, Nilesh J., Nixon, Jane, Hall, Alistair S., and Balmforth, Anthony J.
- Subjects
GENETIC research ,STATINS (Cardiovascular agents) ,CORONARY heart disease prevention ,MYOCARDIAL infarction ,MANAGEMENT science ,LOW-cholesterol diet - Abstract
The article discusses a research study on Genetic Effects On STATins (GEOSTAT-1) and the influence of hepatic metabolism and transporter gene variants on the response of subjects to statin therapy. Subjects were 601 patients in a randomized and controlled trial to compare 40 milligrams (mg) of simvastatin and 10 mg of rosuvastatin and genotyping functional single nucleotide polymorphins including cytochrome and metabolic enzyme-gene coding. The results suggest that patients given rosuvastatin achieved their LDL cholesterol target more frequently.
- Published
- 2010
- Full Text
- View/download PDF
16. Role of autonomic dysregulation in quality of life and functional impairment in implantable cardioverter defibrillator patients.
- Author
-
Costa, Tiago, Bagnall, Alan, Murray, Stephen, Bailey, Kristian, MacGowan, Guy, Ng, Wan-Fai, McKinnon, Iain, Watson, Stuart, and McAllister-Williams, R. Hamish
- Subjects
- *
IMPLANTABLE cardioverter-defibrillators , *QUALITY of life , *HEART failure - Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.